In some of his first public remarks since getting booed on stage last month over Alzheimer’s drug remarks, Regeneron’s George Yancopoulos acknowledged in an interview he could’ve handled things differently.
News
STAT+: Pharmalittle: Biden administration to fine drugmakers for price hikes on 27 meds; Dems push pharmacy chains over access to abortion pill
The Biden administration will fine drugmakers that hiked prices faster than the inflation rate on 27 medicines administered in physician offices. […]
News
STAT+: New Biogen CEO: New drug launches, more cost cuts, but no ‘radical left turns’ needed
SAN FRANCISCO — In some of his first extended comments since taking over as Biogen’s CEO, Chris Viehbacher described the commercial launches this year of an Alzheimer’s treatment and a… […]
News
STAT+: 4 ways the health care system should shift its thinking on AI, according to experts
“People are thinking of ChatGPT as like a box. The progress in the field has not been this box,” one expert said at #STATBreakthrough. It’s all the technology inside it. […]
